Free Trial

MBX Biosciences (MBX) SEC Filings & 10K Form

MBX Biosciences logo
$7.79 -0.34 (-4.18%)
Closing price 04:00 PM Eastern
Extended Trading
$7.77 -0.02 (-0.26%)
As of 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MBX Biosciences SEC Filings

DateFilerForm TypeView
03/17/2025
7:34 AM
MBX Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/17/2025
7:07 AM
MBX Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
7:14 AM
MBX Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
4:52 PM
MBX Biosciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:56 PM
GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:17 PM
Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:17 PM
Bartram Richard (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:17 PM
Azoulay Salomon (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
6:21 AM
MBX Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM
MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2024
7:31 AM
MBX Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:08 AM
MBX Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:38 PM
Hawryluk P. Kent (Filed by)
MBX Biosciences (Subject)
Form SC 13G
09/23/2024
5:05 PM
MBX Biosciences (Subject)
New Enterprise Associates 17, L.P. (Filed by)
Form SC 13D
09/23/2024
5:07 PM
MBX Biosciences (Subject)
Norwest Venture Partners XVI, LP (Filed by)
Form SC 13D
09/23/2024
3:34 PM
MBX Biosciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D
09/23/2024
9:48 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
MBX Biosciences (Subject)
Form SC 13D
09/20/2024
9:13 AM
MBX Biosciences (Subject)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Filed by)
Form SC 13G
09/17/2024
7:20 PM
Makhzoumi Mohamad (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:21 PM
Florence Anthony A. Jr. (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:23 PM
Chang Carmen (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:24 PM
Behbahani Ali (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:26 PM
BASKETT FOREST (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:28 PM
Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:07 PM
Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:09 PM
Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:11 PM
CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:11 PM
FHMLS X, L.L.C. (Reporting)
FHMLS X, L.P. (Reporting)
Frazier Life Sciences X, L.P. (Reporting)
MBX Biosciences (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:12 PM
MBX Biosciences (Issuer)
NEA 17 GP, LLC (Reporting)
NEA Partners 17, L.P. (Reporting)
New Enterprise Associates 17, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:13 PM
MBX Biosciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:14 PM
MBX Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:17 PM
MBX Biosciences (Issuer)
Yang Rick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:18 PM
MBX Biosciences (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:05 PM
GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
7:05 PM
Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
6:15 PM
MBX Biosciences (Issuer)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:21 PM
MBX Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:17 PM
MBX Biosciences (Issuer)
Ryder Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:19 PM
GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:00 PM
MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:02 PM
CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
DOGE could send 6 AI stocks through the roof (Ad)

Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.

Click here to find out what DOGE's next move is.
09/13/2024
4:04 PM
Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:04 PM
Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:06 PM
Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:11 PM
Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:11 PM
Azoulay Salomon (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:13 PM
Bartram Richard (Reporting)
MBX Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:26 PM
MBX Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/12/2024
11:15 PM
MBX Biosciences (Filer)
Form EFFECT
09/12/2024
6:52 PM
MBX Biosciences (Issuer)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:36 PM
MBX Biosciences (Issuer)
Walker Paul Edward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:38 PM
MBX Biosciences (Issuer)
Yang Rick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:15 PM
FHMLS X, L.L.C. (Reporting)
FHMLS X, L.P. (Reporting)
Frazier Life Sciences X, L.P. (Reporting)
MBX Biosciences (Issuer)
Topper James N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:15 PM
GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:17 PM
MBX Biosciences (Issuer)
Ryder Steven (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:17 PM
Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:19 PM
MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:19 PM
MBX Biosciences (Issuer)
NEA 17 GP, LLC (Reporting)
NEA Partners 17, L.P. (Reporting)
New Enterprise Associates 17, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:20 PM
Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:22 PM
BASKETT FOREST (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:23 PM
CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:24 PM
Behbahani Ali (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:26 PM
Chang Carmen (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:27 PM
Florence Anthony A. Jr. (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:29 PM
Makhzoumi Mohamad (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:31 PM
Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:33 PM
MBX Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:34 PM
Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:09 PM
Bartram Richard (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:10 PM
Azoulay Salomon (Reporting)
MBX Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:14 PM
MBX Biosciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
5:05 PM
MBX Biosciences (Filer)
Form S-1MEF
09/12/2024
11:11 AM
MBX Biosciences (Filer)
Form CERT
09/10/2024
3:28 PM
MBX Biosciences (Filer)
Form 8-A12B
09/09/2024
5:06 AM
MBX Biosciences (Filer)
Form S-1/A
08/30/2024
4:13 PM
MBX Biosciences (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:MBX) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners